CorMedico s.r.o.

At CorMedico s.r.o. in Bruntál, clinical research concentrates on cardiovascular health. The program targets acute myocardial infarction, atherosclerotic disease linked to obesity, and heart failure with preserved or mildly reduced ejection fraction. Trials are designed to test new therapies that may lower cardiovascular events and improve patient‑initiated care.

• Acute myocardial infarction treatment strategies
• Management of atherosclerotic cardiovascular disease in overweight individuals
• Heart failure with preserved or mildly reduced ejection fraction combined with obesity
• Evaluation of novel agents to reduce major adverse cardiovascular events (MACE)

Four active studies involve four investigators, each aiming to demonstrate clinical benefit over standard care. The ultimate goal is to reduce morbidity and mortality from heart disease across the Czech population.